2025. Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions. International Journal of Environmental Sciences. (Oct. 2025), 5496–5502. DOI:https://doi.org/10.64252/69nwp181.